CASTLE BIOSCIENCES, INC. (CSTL) Operating cash flow 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$64.3MFY2025 · since FY2018: -$12.3M → $64.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.3M | -0.8% |
| FY2024 | $64.9M | +1253.0% |
| FY2023 | -$5.6M | +86.5% |
| FY2022 | -$41.7M | -119.4% |
| FY2021 | -$19.0M | -292.4% |
| FY2020 | $9.9M | +40.6% |
| FY2019 | $7.0M | +157.1% |
| FY2018 | -$12.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating incomeCSTL Operating marginCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →